Pletaal SR Post Marketing Observational Study

• Status: Unknown status
• Trial end date: 0000-00-00

Summary

This is a Post Marketing Observational Study of cilostazol (Pletaal® SR capsule). As this study is observational in nature to collect the safety data after administrating the Pletaal SR capsule, from baseline to 16 weeks.

• Phase: N/A

Details

• Lead Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.